menu search

IBBQ / Cap-Weighting Crucial When Indexing Biotech

Cap-Weighting Crucial When Indexing Biotech
The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams because their new drug or treatment is still in development, hasn't received FDA approval, or hasn't been in the market long enough to establish a proven track record. Read More
Posted: Jan 25 2022, 13:53
Author Name: ETF Trends
Views: 110560

IBBQ News  

IBBQ: Healthcare Dashboard For December

By Seeking Alpha
December 18, 2022

IBBQ: Healthcare Dashboard For December

The pharmaceuticals/biotechnology subsector has good value and quality scores. The healthcare equipment industry is significantly overvalued. more_horizontal

Battered Biotech Space Now Unbelievably Inexpensive

By ETF Trends
May 6, 2022

Battered Biotech Space Now Unbelievably Inexpensive

After disappointing in 2021, biotechnology stocks and exchange traded funds are getting shellacked this year as growth stocks fall out of favor due to more_horizontal

Cap-Weighting Crucial When Indexing Biotech

By ETF Trends
January 25, 2022

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams beca more_horizontal

Cap-Weighting Crucial When Indexing Biotech

By ETF Trends
January 25, 2022

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams beca more_horizontal

Cap-Weighting Crucial When Indexing Biotech

By ETF Trends
January 25, 2022

Cap-Weighting Crucial When Indexing Biotech

The biotechnology industry is a bifurcated space. In one corner, you have nascent, small-cap companies that don't yet have steady revenue streams beca more_horizontal


Search within

Pages Search Results: